Taro Pharmaceutical Industries Ltd (NYSE:TARO)

117.50
Delayed Data
As of Jun 22
 -1.36 / -1.14%
Today’s Change
93.01
Today|||52-Week Range
128.46
+12.21%
Year-to-Date
Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy
Jun 19 / Zacks.com - Paid Partner Content
Is Taro Pharmaceutical Industries (TARO) Stock Outpacing Its Medical Peers This Year?
Jun 15 / Zacks.com - Paid Partner Content
6 Companies With Growing Book Value
Jun 18 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close118.86
Today’s open119.03
Day’s range117.35 - 119.03
Volume47,878
Average volume (3 months)74,969
Market cap$4.5B
Data as of 4:01pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-12.51%
Earnings growth (this year)-52.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-7.51%
P/E ratio22.3
Price/Sales5.48
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.38+2.38%
AKRXAkorn Inc+0.27+1.71%
----
MNKMallinckrodt Plc-0.17-0.87%
Data as of 4:02pm ET, 06/22/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$1.98
Annual revenue (last year)$879.4M
Annual profit (last year)$456.4M
Net profit margin51.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts